Abstract
661 - Combination of BGJ398 with either a pan-PI3K inhibitor or a specific PIK3CA inhibitor shows synergy in FGFR2 mutant endometrial cancer cell lines
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have